Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for vTv Therapeutics (VTVT) over the last 10 years, with Q3 2025 value amounting to -$34000.0.

  • vTv Therapeutics' Other Non Operating Income fell 14000.0% to -$34000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $325000.0, marking a year-over-year increase of 31959.46%. This contributed to the annual value of $160000.0 for FY2024, which is 11068.8% up from last year.
  • As of Q3 2025, vTv Therapeutics' Other Non Operating Income stood at -$34000.0, which was down 14000.0% from $54000.0 recorded in Q2 2025.
  • In the past 5 years, vTv Therapeutics' Other Non Operating Income registered a high of $2.9 million during Q2 2021, and its lowest value of -$3.6 million during Q3 2023.
  • Over the past 5 years, vTv Therapeutics' median Other Non Operating Income value was $35500.0 (recorded in 2023), while the average stood at -$139166.7.
  • Per our database at Business Quant, vTv Therapeutics' Other Non Operating Income tumbled by 100322.58% in 2023 and then skyrocketed by 185882.35% in 2024.
  • Quarter analysis of 5 years shows vTv Therapeutics' Other Non Operating Income stood at $634000.0 in 2021, then plummeted by 197.48% to -$618000.0 in 2022, then soared by 102.75% to $17000.0 in 2023, then skyrocketed by 1858.82% to $333000.0 in 2024, then plummeted by 110.21% to -$34000.0 in 2025.
  • Its last three reported values are -$34000.0 in Q3 2025, $54000.0 for Q2 2025, and -$28000.0 during Q1 2025.